MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 

Location: Categories / Finance & Investment / Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.
Old Articles: <Older 26421-26430 Newer>
The Motley Fool
October 2, 2007
Markos Kaminis
A Gem in the Financial Rough SEI Investments has provided investors with steady, reliable growth over the years. Here's how the stock stacks up. mark for My Articles 7 similar articles
The Motley Fool
October 2, 2007
Ryan Fuhrmann
Fool on the Street: Mueller Water Handles the Pressure Despite residential housing exposure, Mueller is well-positioned in water infrastructure. There's some near-term risk, given that Mueller's Class A shares trade at 18 times earnings expectations for 2007. mark for My Articles 15 similar articles
The Motley Fool
October 2, 2007
Dave Mock
Navteq Locates Cash in Finland Nokia makes a big commitment to location services with its Navteq purchase. Investors, take note. mark for My Articles 457 similar articles
The Motley Fool
October 2, 2007
Rich Duprey
Guiding Higher or Guiding Nowhere? A look at how one of the stock ideas we've run in the past has performed since. mark for My Articles 40 similar articles
The Motley Fool
October 2, 2007
Ryan Fuhrmann
Fool on the Street: Lowe's Plan for Improvement Despite significant near-term challenges, Lowe's has a long-term plan. Investors, take note. mark for My Articles 245 similar articles
The Motley Fool
October 2, 2007
Ryan Fuhrmann
Clean Bill of Health at Jabil? So far this year, investors have little to show for sticking with Jabil Circuit, even despite a recent return to profitability for the electronic manufacturing service provider. mark for My Articles 48 similar articles
The Motley Fool
October 2, 2007
Brian Orelli
Amylin's Bittersweet FDA News Diabetes drug moves ahead, but not as much as the company wanted. If the FDA rejection was due to safety issues, that wouldn't bode well for Amylin's plans to develop the active ingredient in SYMLIN as a weight-loss drug. Investors, take note. mark for My Articles 564 similar articles
The Motley Fool
October 1, 2007
Anders Bylund
Fool on the Street: Disney's Growth Model Disney CFO Tom Staggs explains how the company grows its business, and where the Mouse is going next. mark for My Articles 591 similar articles
The Motley Fool
October 1, 2007
Tim Beyers
Treo Lite Is No Delight Palm responds to iPhone with its introduction of a $99 smartphone dubbed Centro. mark for My Articles 878 similar articles
The Motley Fool
October 1, 2007
Mac Greer
Fool Video: Is Chipotle Overvalued? Shares of Chipotle Mexican Grill have nearly doubled in the past six months. Is Chipotle's valuation too rich? Or is it the next Starbucks? These questions are discussed in this video. mark for My Articles 367 similar articles
<Older 26421-26430 Newer>    Return to current articles.